Skip to content
Menu

JP Morgan Maintains Underweight on Moderna, Raises Price Target to $102

Benzinga Newsdesk 2 days ago

Analyst RatingsNewsPrice TargetHot

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

JP Morgan analyst Jessica Fye maintains Moderna (NASDAQ:MRNA) with a Underweight and raises the price target from $77 to $102.

JP Morgan analyst Jessica Fye maintains Moderna (NASDAQ:MRNA) with a Underweight and raises the price target from $77 to $102.

Read at benzinga.com